chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bell's Palsey after receiving the vaccine; This is a spontaneous report from a Pfizer-sponsored program. A non-contactable consumer reported for a patient.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/lot number was not reported), via an unspecified route of administration, on an unspecified date at a dose number unknown, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient developed Bell's Palsey. The reporter stated a family member developed Bell's Palsey after receiving the vaccine. The reporter had first hand knowledge of the patient and was reporting on a specific patient. The reporter stated that she is not going to get the vaccine. The outcome of the event was unknown.  No follow up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Sore arm shoulder. Stiffness neck stiff. Unable to left arm at times.
Starting on 12/3/2021, I started to get slight itching at the back of my head. I had assumed it was a regular rash or mosquito bite. On 12/4/2021, I broke out in full body hives, accompanied by itchiness as well. I also experienced slight swelling in the hands, and arm soreness where the hives were. Overnight 12/4/2021 in 12/05/2021 I had difficulty swallowing as well. This lasted until 12/06/2021. Then, on 12/08/2021, the hives continued to intensify into hand/joint pain. The pain was more intense in the same arm as I received my Moderna booster shot. I could barely close my hand, along with the joint pain, inflammation, and redness. I proceeded to the ER on 12/08/2021 which is when they said it could be from the vaccine and diagnosed me with urticaria. They prescribed Prednisone 40mg over the course of four days. Over these four days it did seem to make the itching go away, but the redness, and hives were still consistent. Today is 12/13/2021 and I am still experiencing full body hives and redness, which I have never had in my life. I also have no allergy history, or a history of skin conditions.
Pt was sitting in father's lap for vaccination.  Pt had a very brief syncopal episode in father's lap (seconds).  Pt complaining of dizziness and parents state that the pt was very nervous before the vaccination.  Pt given juice and crackers.  Pt taken to medical tent. Vitals: BP 103/68, HR 84, O2 Sat 100% -- > 104/68, 84, 100% VSS, pt symptoms resolved and has no further complaints.  Strong steady gate upon leaving.  Instructed parents to seek medical attention if any concerning symptoms develop.  Recommended that patient f/u w/ their PCP.  Pt stable and released from the vaccination site.
Mom into child with patients sisters. Mom asked PHN to look at his arms. Redness and swelling to both right and left arm where pt received. Mom reported his arms began to swell on 3-28-07. Pt is very playful without any fever. Doctor evaluated child and ordered elevate arm, cool compress. Benadryl TID x Advil with Motrin TID. RTC in am for recheck
Nausea, cramping, gas, burping and flatulence.  Duration: 2 hours
In Aug2021, diarrhea, stomach issues one night, the next day irritated throat. 3rd day I work I had really bad night sweats, body aches and sore throat . ER Aug2021 - body aches , really tired and body. Still now, I get really tired really easily. Every now and then I get an irritated throat and achy.
This is a solicited report from a non-Pfizer sponsored program (marketing program name FACILITATED COLLECT) received from a contactable consumer (patient's caregiver), based on information received by Pfizer from the (manufacturer control number 21K-163-4121505-00).  An 81-year-old elderly male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 intramuscular on an unspecified date (Batch/Lot number, expiration date was not reported) as single dose for COVID-19 Vaccination; and adalimumab (HUMIRA, Solution for injection in pre-filled pen), Subcutaneous from an unspecified date (Batch/Lot number, expiration date was not reported) to an unspecified date, at unspecified dose for Moderate to severe adult Crohn's disease. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient experienced fatal COVID-19. On unknown date, the patient died. The cause of death was reported as COVID-19. It is unknown if an autopsy was performed. The patient's caregiver reported that patient died of COVID-19. The action taken in response to the event for adalimumab was Not Applicable. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's Causality for adalimumab with the event was a reasonable possibility. The reporter's Causality for bnt162b2 with the event was possible.   The lot number for the vaccine bnt162b2, was not provided and will be requested during follow up.; Sender's Comments: Based on the reported information ,a causal relationship between the events and suspected drug cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate; Reported Cause(s) of Death: COVID-19; COVID-19
Received full dose MODERNA booster per health hx.  Pt c/o itchy tongue and throat within 10 minutes of booster shot.  2 benadryl were given and pt was advised to take 1-2 benedryl every 6 hrs for 3 days per the Urgent Care physician.
Patient had swelling and redness on inner arm, not at the injection site that started after she received the shot.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022). No concomitant product use was reported. Patient received half dose. The number of doses/vials administered were 35 vials. On 04-Jun-2022 the vials were initially stored in the refrigerator. The vaccines were administered from the 04-Jun-2022 until the 26-Jul-2022. Vial did not undergone any temperature excursions. No treatment information was provided.
I developed Bullous Pemphigoid...intense, itching rash with giant vesecles leaving me unable to sleep through the night getting bigger over the next 60 days following the booster. I understand from my doctor this now become a life time choonic condition.
Pt had severe headache, her entire upper half of her body was sore, and she had chest pain that lasted 2 days and then resolved.
Shaking, jaw clenching, vomiting blurred vision tingling in arms and legs loss of sensation in arms and legs.
Urticarial rash on face - raised red patches - resolved after Benadryl dose x 1.
First 48 hours fever 101 degrees, chest pain, aches, chills, unable to sleep due to pain everywhere Approximately 6 days later severe vertigo.....now still soon 4 weeks later, off and on vertigo mild to moderate. Blood work on 3/10/21 my basophils is high and my mean corpus all hemoglobin concentrate low.  Two months  before this shot, everything was normal
101.7 F fever, nausia, tiredness, runny nose, headache the night and day after the vaccine, that went away after 48 hours.
Pain at site of injection started 8/9/11 at 8:00pm and by 8/10/11 10:00am aching joints in arm shot was given, area 4 inches in diameter firm to touch, no redness or fever noted. Patient called me 8/10/11 after 10:00am to report side affects.   Patient had been icing the site occasionally since the initial pain started the day before.  I instructed her on continuing icing site and to take pain medication/anti-inflammatory medication and on symptoms to report to MD if symptoms worsened. TC to patient on 8/11/11 and she states arm is greatly improved and she had been icing vigorously and taking Excedrin around the clock, no more swelling or firmness at site and all joint discomfort is gone.
Nauseous; Tired; Fever was between 103-105/Fever was at a low 100 for 48 hours/Extreme high temperature; 106 fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERPYREXIA (106 fever), NAUSEA (Nauseous), FATIGUE (Tired) and PYREXIA (Fever was between 103-105/Fever was at a low 100 for 48 hours/Extreme high temperature) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPERPYREXIA (106 fever). On 26-Mar-2021, the patient experienced NAUSEA (Nauseous) and FATIGUE (Tired). 26-Mar-2021, the patient experienced PYREXIA (Fever was between 103-105/Fever was at a low 100 for 48 hours/Extreme high temperature). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 1 Tylenol. On 28-Mar-2021, PYREXIA (Fever was between 103-105/Fever was at a low 100 for 48 hours/Extreme high temperature) had resolved. At the time of the report, HYPERPYREXIA (106 fever), NAUSEA (Nauseous) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Body temperature: 106 (High) 106 fever., 103-105 (High) Fever was between 103-105. and high (High) Fever was at a low 100 for 48 hours..         Patient stated that his fever was at a low 100 for 48 hours. Patient was taking other medications which were not reported. Oncologist was aware of the side effects.
This spontaneous report was received from a nurse practitioner via a company representative and refers to a 52 year old female patient with chronic obstructive pulmonary disease (COPD). No information regarding the patient's concomitant medication and drug reactions or allergies was reported. On 06-NOV-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 in the arm (strength, dose, route of administration, lot # and expiration date were not provided). On the same date, the patient was vaccinated with influenza virus vaccine (unspecified) in the arm (strength, dose, route of administration, lot # and expiration date were not provided). No indication was given as to which arm or the timing of the 2 shots. Later on 06-NOV-2015, the patient returned to the nurse practitioner's office and complained of "warm and swollen arm".  On 09-NOV-2015, the patient returned to the nurse practitioner's office and her arm was still "red and swollen" (onset date of arm's redness estimated to November 2015). It was unspecified if the patient received the treatment and had lab diagnostics studies performed. The patient notified the nurse practitioner that she was feeling better and recovering from the events. The patient sought medical attention. The relatedness between the events and PNEUMOVAX 23 and influenza virus vaccine (unspecified) was not reported. Additional information has been requested.
healthy kid with no health  issues or ever illnesses.    woke up in middle of night  day after 2nd vaccination with sever chest pain.   he had shortness of breathe. checked blood pressure  and pulse, and both were very high.    gasped for air often  kept him upright all night.  As of 6/14 he is still slightly gasping for deep breathes and it is hard for him to  concentrate.   has pressure in chest.  seeking pediatric cardiologist.
Intermittent dizziness and vertigo, lasting for a few hours 2 days after vaccine. Tinnitus in right ear 3 days after vaccine.
Muscle aches similar to the flu, headache, fatigue, sour stomach, arm soreness where the shot was administered. Treating symptoms with ibuprofen.
Pt developed swelling, redness in right arm within several hours after received vaccination. T 100.6. Called about symptoms next morning. Swelling and induration of right mid arm continued, T < 101. Seen 5/7/17 in office around 10:30 am. Felt pt had local reaction with possible early cellulitis, started pt on oral Clindamycin (with recent allergic reaction to amoxicillin did not want to use AUGMENTIN or KEFLEX). After 2 doses oral antibiotic pt's temp 101.8, with continued redness and swelling and warmth of arm, admitted 5/8/17 to Hospital, for IV Clindamycin. Discharged 5/9/17 about 39 hours later with improvement in swelling (almost completely resolved mid arm) and resolving erythema, good range of motion all joints, afebrile, on oral Clindamycin for 7 more days.
Numb legs, over sensive skin, pain in joints and muscles, tingles all over body and dizzy vomiting. 9/10/02 Per Hospital D/C Summary add bilateral extremity weakness, L side > R side, legs > arms, of uncertain etiology./awb
Information has been received from a licensed vocational nurse concerning a 32 month old male who on 8/5/02 was vaccinated, into the left deltoid, with a dose of pneumococcal vaccine 23 polyvalent (lot 641116/1160L). Concomitant therapy included Atrovent, Zyrtec, montelukast sodium, Serevent, Flovent, and Zithromax. That evening, on 8/5/02, the pt awoke from sleep with a fever of 104.7 F axillary and severe pain at the injection site. The next day, on 8/6/02, the fever continued and abdominal pain began. The symptoms continued with no relief, and on 8/8/02, the pt was admitted to the hospital, where he was treated with "unknown IV antibiotics." The symptoms resolved and the pt was discharged from the hospital on 8/11/02. Additional info has been requested.
Muscle aches; Joint aches; Malaise; Headache and earache on left side of head; Headache and earache on left side of head; Nausea; Lightheadedness; Fatigue; Alternating between the chills and feeling feverish; Feverish; Chest pain; Dry mouth; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO179) via an unspecified route of administration in the left arm on 06May2021 at 12:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included raynaud's phenomenon and polycystic ovarian syndrome. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3), amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL) and bupropion hydrochloride (WELLBUTRIN); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO153) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 03:00, the patient experienced muscle/joint aches, malaise, headache and earache on left side of head, nausea, lightheadedness, fatigue, alternating between the chills and feeling feverish, chest pain, dry mouth and brain fog. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle/joint aches, malaise, headache and earache on left side of head, nausea, lightheadedness, fatigue, alternating between the chills and feeling feverish, chest pain, dry mouth and brain fog was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
This case was reported by a healthcare professional and described the occurrence of swelling of legs in a subject of unspecified age and gender who was vaccinated with KINRIX (GlaxoSmithKline).  On an unspecified date the subject received unspecified dose of KINRIX (unknown).  At an unspecified time after vaccination with KINRIX, the subject experienced swelling of legs.  At the time of reporting the outcome of the swelling of legs was unspecified.  The healthcare professional made an initial report of swelling around the legs, see case A0883031A.  During the report it was stated that the healthcare professional's "colleague had two similar events over the past four weeks"; see case A0883034A.  The representative stated the provider has already reported the events via VAERS.
back was hurting; chest was hurting; Couldn't breathe; very high potassium levels; A spontaneous report , was received from a consumer, concerning herself an 81 -year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Couldn't  breathe, back was hurting , chest was hurting, very high potassium levels.  The patient's medical history was not reported by the reporter .miralax , Flonase nitroglycerin , ondansetron hydrocodone , ranolavine, floresimide, loretedine, clotigogrel, Tamsulosin, gabapentin,sadrovastadin, sertraline , sinoxidil  for drug use for unknown indication.  On 03 MAR 2021, the patient received the first of two planned doses of mRNA-1273 (Batch number: 012A21A) intramuscularly in left arm for prophylaxis of COVID-19 infection.  On 03 MAR 2021, the patient couldn't breathe, hurting back, hurting chest ,high potassium levels .The patient took nitroglycerin and was admitted to hospital, vitals were ok. The patient was administered with breathing treatment.  The action taken with the first dose of mRNA-1273 in response to the events was not reported.   The outcome of the events Couldn't breathe, back was hurting , chest was hurting, very high potassium levels was resolving .; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
low platelets; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT DECREASED (low platelets) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Elevated Transaminase Level, Fatty Liver, Lumbar Adrenal Mass, Kidney Stone, Essential Hypertension, Hyperlipidemia, Vitamin D Deficiency, Gastroesophageal Reflux disease with out esophagitis, Rosacea, Migraines, Asthma, PTSD, Panic attacks, Anxiety, Low grade Bells palsy (from recent face surgery), pre diabetes.  Gallbladder Surgery 10/2016  Uterine Ablation 1/2013 Parotid Gland 3/15/21  Allergies: Doxycycline, Nitrofurantoin, Lisinopril, Sulfa antibiotics, Sumatriptan.  The patient's past medical history included Gallbladder operation NOS in October 2016 and Uterine ablation in January 2013. Concurrent medical conditions included Fatty liver, Adrenal mass (Lumbar Adrenal Mass), Kidney stone (Kidney Stone), Essential hypertension, Hyperlipidemia, Vitamin D deficiency, Gastroesophageal reflux disease (with out esophagitis), Rosacea, Migraine, Asthma, Post-traumatic stress disorder, Panic attacks, Bell's palsy (Low grade Bells palsy from recent facial surgery), Parotid gland enlargement of (Parotid Gland) since 15-Mar-2021, Allergic reaction to antibiotics (Doxycycline), Allergic reaction to antibiotics (Nitrofurantoin), Allergic reaction to antibiotics (Lisinopril), Allergic reaction to antibiotics (Sulfa) and Allergic reaction to drug (Sumatriptan).   On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PLATELET COUNT DECREASED (low platelets). At the time of the report, PLATELET COUNT DECREASED (low platelets) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Transaminases: other (High) Elevated Transaminase Level.   Concomitant medications were not provided.  Treatment information was not provided.
ACID REFLUX (STOMACH BLOATING, STOMACH ACHE, STOMACH FLUTTER, NAUSEA); ISSUE WITH ARTICULATION; BACK ACHE; UNABLE TO WALK; CHEST ACHING (CHEST HEAVY); RADIATING; LEG ACHES; FEELING SICK; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included gerd. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and batch number: 1805022 expiry: 25/MAY/2021) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced acid reflux (stomach bloating, stomach ache, stomach flutter, nausea). On 09-MAR-2021, the subject experienced issue with articulation. On 09-MAR-2021, the subject experienced back ache. On 09-MAR-2021, the subject experienced unable to walk. On 09-MAR-2021, the subject experienced chest aching (chest heavy). On 09-MAR-2021, the subject experienced radiating. On 09-MAR-2021, the subject experienced leg aches. On 09-MAR-2021, the subject experienced feeling sick. On 09-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from issue with articulation, back ache, unable to walk, chest aching (chest heavy), radiating, leg aches, feeling sick, and headache on 10-MAR-2021, and was recovering from acid reflux (stomach bloating, stomach ache, stomach flutter, nausea). This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard procedure as case assessed as non serious.